The global Pelvic Inflammatory Disease (PID) treatment market is expected to increase from USD 3.65 billion in 2025 to around USD 5.09 billion by 2034, marking a projected CAGR of 3.75%. Rising STI cases and heightened public awareness continue to fuel this steady market expansion.